Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (41-50 of 375) with videos related to

Pageof 38
Sort By:
Cancers|February 25, 2022
The New Era of Immunotherapy in Gastric CancerShogo Takei, Akihito Kawazoe, Kohei Shitara
International Journal of Clinical Oncology|April 13, 2019
Dawn of precision medicine on gastric cancerTakahiro Ishii, Akihito Kawazoe, Kohei Shitara
Expert Opinion on Biological Therapy|January 16, 2026
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agentsKazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Current Oncology Reports|January 3, 2025
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New InsightsYu Aoki, Izuma Nakayama, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 8, 2024
[A New Molecular Targeted Agent for Gastric Cancer-The Anti-Claudin 18.2 Antibody, Zolbetuximab]Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Cancer Cell|July 11, 2023
Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapyShogo Kumagai, Shohei Koyama, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in AsiaYoshiaki Nakamura, Kohei Shitara, Jeeyun Lee
In Vivo (Athens, Greece)|April 28, 2019
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric CancerKohei Shitara, Yasuhide Yodo, Shuichi Iino
JAMA|February 10, 2011
KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximabKohei Shitara, Tomoya Yokota, Kei Muro
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[Which chemotherapy regimens should we choose for 1st or 2nd line of metastatic colorectal cancer?]Ayako Mizota, Kohei Shitara, Kei Muro
Pageof 38

Showing results (41-50 of 375) with videos related to

Sort By:
Pageof 38
Cancers|February 25, 2022
The New Era of Immunotherapy in Gastric CancerShogo Takei, Akihito Kawazoe, Kohei Shitara
International Journal of Clinical Oncology|April 13, 2019
Dawn of precision medicine on gastric cancerTakahiro Ishii, Akihito Kawazoe, Kohei Shitara
Expert Opinion on Biological Therapy|January 16, 2026
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agentsKazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Current Oncology Reports|January 3, 2025
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New InsightsYu Aoki, Izuma Nakayama, Kohei Shitara
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 8, 2024
[A New Molecular Targeted Agent for Gastric Cancer-The Anti-Claudin 18.2 Antibody, Zolbetuximab]Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Cancer Cell|July 11, 2023
Precise patient stratification in esophageal cancer: Biomarkers for immunochemotherapyShogo Kumagai, Shohei Koyama, Kohei Shitara
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in AsiaYoshiaki Nakamura, Kohei Shitara, Jeeyun Lee
In Vivo (Athens, Greece)|April 28, 2019
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric CancerKohei Shitara, Yasuhide Yodo, Shuichi Iino
JAMA|February 10, 2011
KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximabKohei Shitara, Tomoya Yokota, Kei Muro
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[Which chemotherapy regimens should we choose for 1st or 2nd line of metastatic colorectal cancer?]Ayako Mizota, Kohei Shitara, Kei Muro
Pageof 38